SRPT Stock Rises 23% in a Year: Time to Buy, Hold or Sell?

SRPT Stock Rises 23% In A Year: Time To Buy, Hold Or Sell?

2 weeks from now

Jan 6, 2025  · SRPT Stock Valuation & Estimates The company is trading at a premium to the industry. Going by the price/sales ratio, the stock currently trades at 7.73, trailing 12-month …

nasdaq.com

SRPT Stock Rises 23% In A Year: Time To Buy, Hold Or Sell?

2 weeks from now

Jan 6, 2025  · Shares of Sarepta Therapeutics (SRPT Quick Quote SRPT - Free Report) have risen 23% in the past year, significantly outperforming the industry’s 15.7% decline, as shown …

zacks.com

Sarepta Therapeutics (SRPT) Stock Forecast & Price Target

2 weeks from now

Sarepta Therapeutics (SRPT) has been analyzed by 35 analysts, with a consensus rating of Buy. 34% of analysts recommend a Strong Buy, 54% recommend Buy, 9% suggest Holding, 0% …

public.com

Summary - SRPT - NASDAQ - Weiss Ratings

2 weeks from now

Jan 6, 2025  · SRPT Stock Rises 23% in a Year: Time to Buy, Hold or Sell? 1/6/2025 - Zacks Investment Research. Sarepta Therapeutics (SRPT, $126.29) entered Uptrend as Momentum …

weissratings.com

Should I Buy Sarepta Therapeutics (SRPT) - Zacks

2 weeks from now

6 days ago  · SRPT Stock Rises 23% in a Year: Time to Buy, Hold or Sell? 01/06/25-6:40AM EST Zacks The Zacks Analyst Blog Highlights Sarepta Therapeutics, ADMA Biologics, Exelixis and …

zacks.com

Sarepta Therapeutics Stock Price Forecast. Should You Buy SRPT?

2 weeks from now

5 days ago  · Buy or Hold candidate since Jan 06, 2025 Loss -2.42%. The Sarepta Therapeutics stock price fell by -1.17% on the last day (Friday, 10th Jan 2025) from $126.27 to …

stockinvest.us

SRPT Stock Price | Sarepta Therapeutics Inc. Stock Quote (U.S.: …

2 weeks from now

2 days ago  · SRPT | Complete Sarepta Therapeutics Inc. stock news by MarketWatch. ... SRPT Stock Rises 23% in a Year: Time to Buy, Hold or Sell? ... Sell Rating on Sarepta Therapeutics …

marketwatch.com

SRPT Price Target - ETF Channel

2 weeks from now

SRPT Stock Rises 23% in a Year: Time to Buy, Hold or Sell? The upside in Sarepta's share price can be attributed to the encouraging sales performance of its DMD gene therapy, which has …

etfchannel.com

Sarepta Therapeutics (NASDAQ:SRPT) Given Sell Rating At HC

2 weeks from now

15 hours ago  · Finally, Royal Bank of Canada reiterated an "outperform" rating and set a $182.00 target price on shares of Sarepta Therapeutics in a report on Monday, October 21st. One …

marketbeat.com

Sarepta Therapeutics, Inc. (SRPT) Stock Price, News, Quote And …

2 weeks from now

SRPT Stock Rises 23% in a Year: Time to Buy, Hold or Sell? Zacks • yesterday Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

yahoo.com

Sarepta Therapeutics Stock Price Today (NASDAQ: SRPT) Quote, …

2 weeks from now

Jan 6, 2025  · SRPT Stock Rises 23% in a Year: Time to Buy, Hold or Sell? ... Sarepta Therapeutics 's market cap is calculated by multiplying SRPT's current stock price of $127.89 …

wallstreetzen.com

Sarepta Maintained At Sell Rating By H.C. Wainwright On 112% Q/Q …

2 weeks from now

15 hours ago  · On Wednesday, H.C. Wainwright analysts reiterated a Sell rating on Sarepta Therapeutics stock (NASDAQ: SRPT).. The firm's analysis follows Sarepta's recent pre …

investing.com

What Date Does Sarepta Therapeutics's (SRPT) Report Earnings

2 weeks from now

Jan 8, 2025  · SRPT Stock Rises 23% in a Year: Time to Buy, Hold or Sell? 01/06/25-6:40AM EST Zacks The Zacks Analyst Blog Highlights Sarepta Therapeutics, ADMA Biologics, Exelixis and …

zacks.com

SRPT Stock Price - Sarepta Therapeutics Inc Stock ... - StockScan

2 weeks from now

5 days ago  · SRPT Stock Rises 23% in a Year: Time to Buy, Hold or Sell? - MSN Jan 08, 2025. Jan 07, 2025. Hansa Biopharma to attend 2025 J.P. Morgan ... (NASDAQ:SRPT) Receives …

stockscan.io

ETFs Containing SRPT - ETF Channel

2 weeks from now

SRPT Stock Rises 23% in a Year: Time to Buy, Hold or Sell? The upside in Sarepta's share price can be attributed to the encouraging sales performance of its DMD gene therapy, which has …

etfchannel.com

SRPT - Sarepta Therapeutics Inc Stock Price Forecast 2025

2 weeks from now

This indicates an $-19.48% rise from the last recorded price of $126.29. Sarepta Therapeutics Inc (SRPT) stock is projected to chart a bullish course in 2040, with an average price target of …

stockscan.io

SRPT Stock Quote - SRPT Stock Price Today - Stock Market Watch

2 weeks from now

Leading Genetic Medicine Company to Showcase Innovations and Engage with InvestorsRelated Stocks: SR... SRPT Stock Rises 23% in a Year: Time to Buy, Hold or Sell? The upside in …

thestockmarketwatch.com